A phase II trial evaluating the efficacy of high‐dose Radioiodinated Tositumomab (Anti‐CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high‐risk relapsed or…

Overview of attention for article published in American Journal of Hematology, April 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 31 Mendeley

So far, Altmetric has seen 1 X post from an account with 925 followers.

New article: A Phase II Trial Evaluating The Efficacy of High-Dose Radioiodinated Tositumomab (Anti-CD20) Antibody, Etoposide and Cyclophosphamide followed by Autologous Transplantation, for High-Risk Relapsed or Refractory… https://t.co/1v4yn436Jx #MCL #…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.